Fosfluconazole
Fosfluconazole
|
Systematic (IUPAC) name |
---|
{[2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-yl]oxy}phosphonic acid |
Clinical data |
---|
AHFS/Drugs.com |
International Drug Names |
---|
|
|
---|
|
IV |
---|
Identifiers |
---|
|
Y |
---|
|
None |
---|
PubChem |
CID 214356 |
---|
ChemSpider |
185843 Y |
---|
UNII |
3JIJ299EWH Y |
---|
ChEMBL |
CHEMBL1908301 Y |
---|
Chemical data |
---|
Formula |
C13H13F2N6O4P |
---|
|
386.25 g/mol |
---|
SMILES
- Fc1ccc(c(F)c1)C(OP(=O)(O)O)(Cn2ncnc2)Cn3ncnc3
|
InChI=1S/C13H13F2N6O4P/c14-10-1-2-11(12(15)3-10)13(25-26(22,23)24,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9H,4-5H2,(H2,22,23,24)
Y
Key:GHJWNRRCRIGGIO-UHFFFAOYSA-N
Y
|
N (what is this?) (verify) |
---|
Fosfluconazole (INN) is a water-soluble phosphate prodrug of fluconazole - a triazole antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. The phosphate ester bond is hydrolysed by the action of a phosphatase - an enzyme that removes a phosphate group from its substrate by hydrolysing phosphoric acid monoesters into a phosphate ion and a molecule with a free hydroxyl group (see dephosphorylation).
|
---|
| Wall/ membrane | | |
---|
| β-glucan synthase inhibitors | |
---|
|
---|
| Intracellular | |
---|
| Others | |
---|
| Index of fungal disease |
---|
| Description | |
---|
| Disease | |
---|
| Treatment | |
---|
|
|